Atherectomy Devices Market Size, Share, and Industry Analysis By Type (Instruments and Accessories), By Product Type (Directional Arthrectomy Systems, Rotational Arthrectomy Systems, and Others), By Application (Coronary Artery Disease and Peripheral Artery Disease), By End User (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

The global atherectomy devices market size was valued at USD 862.62 million in 2025 and is projected to grow from USD 922.09 million in 2026 to USD 1571.7 million by 2034, exhibiting a CAGR of 6.89% during the forecast period.

The Atherectomy Devices Market represents a critical segment within the global interventional cardiology and vascular treatment landscape. Atherectomy devices are designed to remove atherosclerotic plaque from blood vessels, restoring blood flow and reducing the risk of cardiovascular complications. These devices are widely used in minimally invasive procedures to treat complex arterial lesions that are difficult to manage with balloon angioplasty alone. The Atherectomy Devices Market is driven by rising prevalence of cardiovascular diseases, technological innovation in device design, and increasing preference for minimally invasive interventions. Hospitals and specialty clinics increasingly adopt atherectomy solutions to improve procedural outcomes. Continuous innovation and expanding clinical indications continue to strengthen the Atherectomy Devices Market outlook.

The United States holds a dominant position in the Atherectomy Devices Market due to advanced healthcare infrastructure and high adoption of interventional cardiology procedures. The country faces a significant burden of coronary artery disease and peripheral artery disease, driving sustained demand for plaque removal technologies. Physicians increasingly utilize atherectomy devices for complex and calcified lesions. Strong reimbursement frameworks and widespread availability of skilled interventional specialists further support adoption. The U.S. market also benefits from early access to technological advancements and strong clinical research activity. High procedure volumes in hospitals and ambulatory surgical centers reinforce consistent demand for atherectomy systems across the country.

Key Findings

Market Size & Growth

• Global Market Size 2025: USD 862.62 million
• Global Market Forecast 2034: USD 1571.7 million
• CAGR (2025–2034): 6.89%

Market Share – Regional

• North America: 39%
• Europe: 27%
• Asia-Pacific: 22%
• Rest of the World: 12%

Country-Level Shares

• Germany: 9% of Europe’s market 
• United Kingdom: 7% of Europe’s market 
• Japan: 6% of Asia-Pacific market 
• China: 8% of Asia-Pacific market

Atherectomy Devices Market Latest Trends

The Atherectomy Devices Market is evolving rapidly, shaped by advancements in device precision, safety, and procedural efficiency. One of the most notable Atherectomy Devices Market trends is the growing adoption of image-guided atherectomy systems that improve lesion visualization and treatment accuracy. Integration of imaging technologies enhances physician confidence during complex interventions. Another trend is the increasing use of atherectomy in peripheral artery disease treatment, particularly for patients with calcified and long lesions. Device manufacturers focus on improving catheter flexibility and plaque removal efficiency. Minimally invasive outpatient procedures are gaining traction, driving adoption in ambulatory surgical centers.

Technological advancements emphasize reduced vessel trauma and improved debris management. The market also sees rising physician training programs aimed at expanding clinical expertise. Demand for combination therapies involving atherectomy and drug-coated balloons is increasing. These trends collectively strengthen Atherectomy Devices Market insights and reinforce the market’s role in advanced cardiovascular care.

Download Free sample to learn more about this report.

Atherectomy Devices Market Dynamics

DRIVER

Rising Prevalence of Cardiovascular and Peripheral Artery Diseases

The primary driver of Atherectomy Devices Market growth is the rising prevalence of cardiovascular diseases and peripheral artery disease globally. Aging populations, sedentary lifestyles, and increasing incidence of diabetes and obesity significantly contribute to arterial plaque buildup. Atherectomy devices offer effective plaque modification and removal, particularly in complex and heavily calcified lesions. Healthcare providers increasingly prefer atherectomy for improved vessel preparation prior to stenting or balloon angioplasty. Growing awareness of early diagnosis and intervention supports procedural volume growth. Technological improvements further enhance safety and effectiveness, reinforcing adoption across clinical settings.

RESTRAINT

High Procedure and Device Costs

High costs associated with atherectomy devices and procedures act as a restraint in the Atherectomy Devices Market. Advanced systems require specialized equipment and trained professionals, increasing overall treatment expenses. Budget constraints in smaller healthcare facilities may limit adoption. Reimbursement variability across regions also influences purchasing decisions. Despite clinical benefits, cost sensitivity remains a concern, particularly in emerging markets. Manufacturers must balance innovation with affordability to expand market penetration.

OPPORTUNITY

Expansion of Minimally Invasive and Outpatient Procedures

Expansion of minimally invasive and outpatient cardiovascular procedures presents a significant opportunity in the Atherectomy Devices Market. Ambulatory surgical centers increasingly perform atherectomy interventions due to reduced hospital stays and faster patient recovery. Technological advancements enabling compact and efficient devices support this shift. Rising patient preference for less invasive treatment options further drives demand. Expanding access to outpatient care opens new growth avenues for manufacturers and healthcare providers.

CHALLENGE

Procedural Complexity and Training Requirements

Procedural complexity and training requirements pose a key challenge for the Atherectomy Devices Industry. Effective use of atherectomy systems requires specialized training and experience. Inadequate expertise may increase procedural risks. Ensuring consistent clinical outcomes depends on physician proficiency and institutional experience. Addressing this challenge requires robust training programs and clinical support initiatives to broaden adoption safely.

Atherectomy Devices Market Segmentation

By Type

Instruments: Instruments account for approximately 62% market share in the Atherectomy Devices Market, making them the most critical component segment. These instruments include core atherectomy consoles and catheter-based systems used directly during plaque removal procedures. Their primary role is precise lesion modification and vessel preparation prior to angioplasty or stent placement. Hospitals and interventional centers prioritize high-performance instruments capable of handling complex and calcified lesions. Continuous improvements in flexibility, torque control, and debris management enhance procedural safety. Physicians favor instruments that allow controlled plaque excision while minimizing vessel trauma. Reusable and high-durability systems support long-term institutional use. Technological upgrades drive replacement demand across healthcare facilities. Compatibility with imaging and guidance systems further strengthens adoption. As procedure volumes increase, demand for advanced atherectomy instruments remains consistently strong.

Accessories: Accessories represent nearly 38% market share in the Atherectomy Devices Market and play a vital supporting role in procedural success. This segment includes guidewires, catheters, introducers, and debris capture components. Accessories ensure compatibility, stability, and navigation accuracy during atherectomy procedures. High reliance on disposable accessories creates recurring demand across hospitals and ambulatory surgical centers. Customization based on vessel anatomy and lesion location enhances clinical outcomes. Manufacturers continuously refine accessory designs to improve deliverability and control. Accessories are often procedure-specific, increasing per-case utilization rates. Growth in complex interventions supports accessory consumption. Regulatory standards emphasize safety and performance consistency. This segment contributes significantly to overall market sustainability through repeat purchasing behavior.

By Product Type

Directional Atherectomy Systems: Directional atherectomy systems hold approximately 41% market share in the Atherectomy Devices Market, reflecting strong physician preference for controlled plaque removal. These systems allow operators to selectively excise plaque by directing cutting mechanisms toward targeted lesion areas. This precision reduces unnecessary vessel wall injury and improves procedural outcomes. Directional systems are widely used in peripheral artery disease treatment, especially in eccentric and complex lesions. Advanced designs offer enhanced visualization and tactile feedback. Physicians value the ability to adjust cutting depth and direction in real time. Ongoing innovations focus on improved catheter flexibility and debris containment. These systems are commonly adopted in both hospitals and specialty clinics. Clinical familiarity and proven outcomes support continued dominance. Directional atherectomy remains a cornerstone technology in vascular interventions.

Rotational Atherectomy Systems: Rotational atherectomy systems account for around 36% market share in the Atherectomy Devices Market and are particularly effective in treating heavily calcified lesions. These devices use high-speed rotating burrs to modify rigid plaque, facilitating subsequent balloon dilation or stent deployment. Rotational systems are widely applied in coronary artery disease interventions. Long-standing clinical acceptance supports their continued use. Physicians rely on rotational atherectomy for lesions resistant to conventional techniques. Technological enhancements focus on improving burr design and procedural control. Compact system configurations support use in catheterization laboratories. Safety features reduce the risk of distal embolization. Rotational atherectomy remains essential for complex coronary procedures. Demand is sustained by increasing calcified lesion prevalence.

Others: Other atherectomy systems represent approximately 23% market share and include orbital, laser-based, and hybrid technologies. These systems address niche clinical scenarios requiring specialized plaque modification approaches. Orbital atherectomy offers circumferential plaque sanding, while laser systems vaporize plaque with high precision. These technologies are often selected for specific lesion characteristics. Adoption is driven by complex case requirements rather than volume procedures. Ongoing innovation improves energy control and vessel safety. Physicians use these systems selectively based on clinical judgment. Training and experience influence adoption rates. Specialty centers often lead usage. While smaller in share, this segment enhances overall treatment versatility. Continued R&D supports gradual expansion.

By Application

Coronary Artery Disease: Coronary artery disease applications account for nearly 48% market share in the Atherectomy Devices Market. Atherectomy is frequently used to treat calcified coronary lesions that limit stent expansion. These devices enable effective lesion preparation, improving procedural success. Increasing prevalence of coronary artery disease drives sustained demand. Aging populations and lifestyle-related risk factors contribute to higher case volumes. Advanced imaging integration enhances treatment precision. Atherectomy is often combined with drug-eluting stents for optimal outcomes. Cardiac catheterization laboratories remain primary treatment settings. Physician expertise strongly influences device selection. Clinical guidelines increasingly support plaque modification strategies. Coronary applications remain a core revenue-generating segment.

Peripheral Artery Disease: Peripheral artery disease represents approximately 52% market share, making it the largest application segment in the Atherectomy Devices Market. Atherectomy devices are widely used in femoropopliteal and below-the-knee interventions. PAD prevalence is rising due to diabetes, smoking, and aging demographics. Atherectomy enables minimally invasive treatment of long and calcified lesions. Improved mobility and symptom relief drive patient demand. Outpatient and ambulatory procedures support growing adoption. Device advancements enhance flexibility and navigation in peripheral vessels. Physicians prefer atherectomy for vessel preservation. Combination therapies increase procedural effectiveness. PAD treatment continues to be the primary growth driver.

By End User

Hospitals & ASCs: Hospitals and ambulatory surgical centers hold around 66% market share in the Atherectomy Devices Market. These facilities perform the majority of complex cardiovascular and vascular procedures. Advanced infrastructure supports high-volume atherectomy usage. Skilled interventional specialists drive consistent procedural demand. ASCs are increasingly performing peripheral atherectomy due to efficiency benefits. Reduced length of stay supports cost optimization. Hospitals invest in advanced systems to manage complex cases. Reimbursement structures favor institutional adoption. Device manufacturers focus on this segment for product launches. Hospitals and ASCs remain the dominant end-user group globally.

Specialty Clinics: Specialty clinics account for approximately 24% market share in the Atherectomy Devices Market. These centers focus on vascular and cardiac care with specialized expertise. Clinics emphasize patient throughput and procedural efficiency. Atherectomy devices enhance their treatment portfolio. Growing referral networks support case volumes. Clinics often adopt advanced systems for competitive differentiation. Outpatient-focused models support cost-effective care delivery. Physician-led purchasing decisions influence adoption. Training and experience enable complex case handling. Specialty clinics represent a growing adoption channel.

Others: Other end users represent nearly 10% market share, including research institutions and specialty care centers. These entities support clinical trials and device evaluation. Usage focuses on innovation and procedural optimization. Academic centers contribute to technique refinement. Training programs utilize atherectomy systems for physician education. Lower procedure volumes limit overall share. However, influence on technology development is significant. Feedback from this segment informs product design. Research-driven adoption supports long-term market advancement. This segment plays a strategic rather than volume-based role.

Atherectomy Devices Market Regional Outlook

North America

North America dominates the Atherectomy Devices Market with approximately 39% market share, reflecting strong adoption of advanced interventional technologies. The region benefits from a highly developed healthcare infrastructure and widespread availability of catheterization laboratories. High prevalence of coronary artery disease and peripheral artery disease continues to drive procedural volumes. Favorable reimbursement frameworks support the use of atherectomy devices in both hospitals and ambulatory surgical centers. Physicians in the region demonstrate high familiarity with plaque modification techniques. Early access to next-generation atherectomy systems accelerates clinical adoption. Combination therapies involving atherectomy and drug-coated balloons are increasingly common. Strong clinical research activity contributes to technology refinement. Aging demographics further sustain demand. North America remains the leading region for innovation, training, and procedural standardization in atherectomy.

Europe

Europe holds around 27% market share in the Atherectomy Devices Market and reflects steady, regulation-driven growth. An aging population and rising burden of cardiovascular diseases support consistent demand for minimally invasive vascular interventions. European healthcare systems emphasize evidence-based adoption and clinical validation of new technologies. Interventional cardiology practices are well established across major countries. Public healthcare funding supports procedural access, particularly in tertiary care hospitals. Regulatory harmonization across the region improves device availability. Clinical research and multicenter trials strengthen physician confidence. Peripheral artery disease treatment represents a key growth area. Increasing focus on limb salvage procedures supports atherectomy usage. Europe remains a mature yet steadily expanding regional market.

Germany Atherectomy Devices Market

Germany represents approximately 9% market share in the Atherectomy Devices Market and is one of Europe’s most advanced national markets. The country benefits from strong healthcare infrastructure and high procedural standards. German hospitals are early adopters of innovative cardiovascular technologies. High prevalence of peripheral artery disease among aging populations drives procedural demand. Physicians emphasize precision and safety in plaque removal techniques. Strong reimbursement mechanisms support advanced device utilization. Clinical research institutions actively participate in device evaluation and optimization. Hospitals prioritize technologically advanced atherectomy systems. Training programs ensure high physician proficiency. Germany continues to serve as a benchmark market for quality-driven adoption in Europe.

United Kingdom Atherectomy Devices Market

The United Kingdom holds nearly 7% market share in the Atherectomy Devices Market and shows growing momentum in minimally invasive cardiovascular care. Rising awareness of peripheral artery disease supports increased diagnostic and treatment rates. National health strategies emphasize early intervention and improved patient outcomes. Atherectomy adoption is supported by specialized vascular centers. Hospitals focus on reducing procedure-related complications through advanced plaque modification techniques. Outpatient and day-case procedures are gaining traction. Physician training and clinical guidelines influence device selection. Public healthcare funding shapes purchasing decisions. Increasing emphasis on limb preservation drives demand. The UK market demonstrates balanced growth across coronary and peripheral applications.

Asia-Pacific

Asia-Pacific captures approximately 22% market share in the Atherectomy Devices Market and represents one of the fastest-expanding regional segments. Rising cardiovascular disease prevalence driven by lifestyle changes fuels demand. Healthcare infrastructure investments across emerging economies support access to interventional procedures. Urbanization and aging populations contribute to increased procedural volumes. Governments are expanding cardiac and vascular care capabilities. Adoption is strongest in major metropolitan hospitals. Increasing physician training improves procedural outcomes. Peripheral artery disease treatment drives a significant portion of demand. Cost sensitivity influences device selection. Asia-Pacific continues to offer strong long-term growth potential for manufacturers.

Japan Atherectomy Devices Market

Japan accounts for around 6% market share in the Atherectomy Devices Market and is characterized by technological sophistication. An aging population significantly contributes to high cardiovascular disease prevalence. Japanese healthcare providers prioritize precision and procedural safety. Advanced imaging and guidance systems support atherectomy procedures. Hospitals emphasize minimally invasive approaches to reduce recovery time. Strong regulatory standards shape device approval and adoption. Physician expertise supports complex interventions. Peripheral artery disease management is a key focus area. Continuous innovation enhances device performance. Japan remains a quality-focused and technology-driven market.

China Atherectomy Devices Market

China represents approximately 8% market share in the Atherectomy Devices Market and demonstrates rapidly growing adoption. Expanding healthcare infrastructure supports increased access to interventional cardiology services. Rising awareness of cardiovascular disease drives diagnostic and treatment rates. Urban hospitals lead atherectomy adoption due to higher procedure volumes. Government healthcare reforms support advanced treatment options. Training initiatives improve physician proficiency. Peripheral artery disease prevalence is increasing among aging and diabetic populations. Cost considerations influence purchasing behavior. Domestic and international manufacturers compete actively. China remains a high-growth market with strong future potential.

Rest of the World

The Rest of the World region holds about 12% market share in the Atherectomy Devices Market and reflects gradual but consistent adoption. Improving healthcare infrastructure across key countries supports procedural growth. Rising incidence of cardiovascular disease drives demand for interventional solutions. Tertiary hospitals lead adoption of atherectomy devices. Government investment in healthcare modernization enhances access. Physician training initiatives support technology uptake. Peripheral artery disease treatment is an emerging focus area. Private healthcare facilities contribute significantly to demand. Cost sensitivity remains a challenge in some markets. The region continues to integrate advanced vascular technologies into clinical practice.

List of Top Atherectomy Devices Companies

• Boston Scientific Corporation
• Abbott
• Medtronic
• Koninklijke Philips N.V.
• Terumo Corporation
• Avinger
• AngioDynamics
• BD

Top Two Companies by Market Share

• Boston Scientific Corporation: 17%
• Medtronic: 14%

Investment Analysis and Opportunities

Investment activity in the Atherectomy Devices Market remains robust as cardiovascular disease prevalence continues to rise globally. Investors are increasingly attracted to companies offering differentiated atherectomy platforms that address complex and calcified lesions. Strong clinical adoption and physician preference play a critical role in shaping investment decisions. Expansion of minimally invasive and outpatient vascular procedures creates new revenue pathways for device manufacturers. Ambulatory surgical centers represent a growing focus area due to procedural efficiency and cost optimization. Emerging markets in Asia-Pacific and Latin America offer long-term growth potential supported by improving healthcare infrastructure. Strategic mergers and acquisitions are used to strengthen product portfolios and geographic reach. Venture capital interest is also increasing in early-stage imaging-integrated atherectomy technologies. Regulatory approvals and reimbursement stability enhance investment confidence. Overall, the market presents sustained opportunities for strategic and financial investors.

New Product Development

New product development in the Atherectomy Devices Market is centered on improving precision, safety, and procedural efficiency. Manufacturers are introducing next-generation atherectomy systems with enhanced plaque modification control. Integration of real-time imaging technologies supports improved lesion visualization and treatment accuracy. Low-profile and flexible catheter designs enable access to complex vascular anatomies. Compact system designs facilitate adoption in outpatient and ambulatory settings. Debris management and embolic protection features are being refined to enhance patient safety. User-friendly interfaces reduce procedural learning curves for physicians. Innovation also focuses on reducing vessel trauma during plaque removal. Compatibility with combination therapies such as drug-coated balloons improves clinical outcomes. Continuous product innovation remains a key differentiator in competitive positioning.

Five Recent Developments (2023–2025)

• Introduction of image-guided atherectomy systems
• Expansion of peripheral artery disease treatment indications
• Development of low-profile atherectomy catheters
• Strategic partnerships to expand global distribution
• Enhanced physician training and education programs

Report Coverage of Atherectomy Devices Market

This Atherectomy Devices Market Research Report provides comprehensive coverage of the global industry landscape. The report analyzes key market drivers, restraints, opportunities, and challenges influencing adoption. Detailed segmentation evaluates device types, product categories, applications, and end users. Regional analysis highlights differences in healthcare infrastructure, disease prevalence, and procedural practices. Competitive landscape assessment profiles leading manufacturers and emerging players. The report examines technology trends shaping next-generation atherectomy systems. Market share analysis supports competitive benchmarking and strategic planning. Regulatory and reimbursement environments are evaluated to assess market accessibility. The report is designed for manufacturers, investors, and healthcare stakeholders. It serves as a decision-support tool for long-term strategic and investment planning within the atherectomy devices industry.

Request for Customization   to gain extensive market insights.

Segmentation